The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results.
 
Martin Wermke
Honoraria - Amgen; BMS GmbH & Co. KG; Boehringer Ingelheim; GWT; Janssen; Lilly; Merck Serono; Merck Serono; Novartis; Pfizer; SYNLAB
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; ImCheck therapeutics; immatics; ISA Pharmaceuticals; Lilly; Novartis; PharmaMar; Regeneron; Tacalyx; Zymeworks
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; GEMoaB; immatics; Iovance Biotherapeutics; Janssen Oncology; Merck Serono; Pfizer; Sanofi/Aventis
 
Juergen Alt
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen; Lilly; MSD; Pfizer; Pierre Fabre; Regeneron; Roche
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Farastuk Bozorgmehr
Honoraria - Abbvie; AstraZeneca; Daiichi Sankyo; GlaxoSmithKline; Janssen; Novartis
Consulting or Advisory Role - Amgen; AstraZeneca; BMS GmbH & Co. KG; Daiichi Sankyo; Janssen; Regeneron
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Florian Fuchs
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson/Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Johnson & Johnson/Janssen; Lilly; Pfizer; Roche
 
Pauline du Rusquec
No Relationships to Disclose
 
Anas Gazzah
No Relationships to Disclose
 
Sean Dulloo
Consulting or Advisory Role - AstraZeneca; RS Oncology
Speakers' Bureau - Advanced Accelerator Applications; AstraZeneca; Chugai Pharma; Roche; RS Oncology; SERVIER
Travel, Accommodations, Expenses - Roche; RS Oncology
 
Ewa Kalinka
Honoraria - AstraZeneca; Bristol-MYERS SQUIBB; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; GlaxoSmithKline; Immutep; MSD; Nektar; Regeneron; Roche
Consulting or Advisory Role - Adamed; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; MSD Oncology
Speakers' Bureau - Bristol-Myers Squibb; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Nektar; Roche
Travel, Accommodations, Expenses - Gilead Sciences; MSD; Roche
 
Aman Chauhan
Stock and Other Ownership Interests - Elicio Therapeutics; Revolution Medicines
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Boehringer Ingelheim; Crinetics Pharmaceuticals; Curium Pharma; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck KGaA (Inst); Nano Therapeutics (Inst); Seneca Therapeutics (Inst); TerSera (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
 
Anna Mosikian
Employment - Boehringer Ingelheim
 
Sabine Kirner
Employment - Boehringer Ingelheim
 
Dian Yang
Employment - Boehringer Ingelheim
 
Cyrus Sayehli
Honoraria - Boehringer Ingelheim (Inst)
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Boehringer Ingelheim; Catalym; Lilly